News and Perspectives | gorerangecapital

Make 2020 Your Decade for Healthy Skin Habits

As a member of the Board of the American Skin Association (ASA), I champion the eradication of skin disease and healthy skin habits as...

Now what? Climate change and skin health?!!!

Global leaders and activists descended upon NYC recently to discuss the implications of climate change on our society. The meeting quickly w

Or-Genix Therapeutics Inc. and Fission Labs Announce Partnership for LATAM Dermatology Markets

WORCESTER, Mass.--(BUSINESS WIRE)-- Or-Genix Therapeutics, Inc., a development-stage specialty woman’s health and dermatology company,...

The Morbid Facts of Skin Co-Morbidities

Our skin is the barrier through which we interact with the world. When that barrier has problems, it can often be an indication of other med

Castle Biosciences Announces Pricing of Initial Public Offering

Castle Biosciences, Inc. announced today the pricing of its IPO of 4,000,000 shares of its common stock at a price of $16/share

Cristina Griffin Joins Or-Genix Therapeutics as Chief Business Officer

Genomic diagnostics provider Castle Biosciences files for a $58 million IPO

Castle Biosciences filed on Wednesday with the SEC to raise up to $58 million in an initial public offering.

Does This Age Make Me Look Old?

The definition of old is becoming increasingly fluid. There is no typical ‘old’ any longer.

Future of Skin Health - Takeaways from IMCAS

Over the past decade, skin health has evolved to become a complex, deep and diverse category that touches a huge portion of the population.

LEO Pharma Joins Gore Range Capital as Strategic Investor

Partnership melds firms' commitment to innovation in dermatology and patient-centric approach.

Gore Range Capital Closes Debut Fund

Gore Range Capital today announced that its first fund is closed to new investors